NeoStrata Skin Active Intensive Eye Therapy

Face the Future £48.99 £69.00 Go to Face the Future First seen in Jan 2022
Price Tracked On This Product
Highest price was seen £69.00 on 23 Dec 2022
Lowest price was seen £53.00 on 13 May 2022
Average price is £52.36 base on 5 price changes
Most recent price is £48.99
Description
NeoStrata Skin Active Intensive Eye Therapy is used to target crow's feet and puffiness with a multi-mechanistic approach that plumps the deep layers of the skin, smoothing lines and wrinkles from the inside out so the eye area appears more lifted. NeoStrata Skin Active Intensive Eye Therapy uses unique SynerG Formula 6.0 that employs a multi-mechanistic approach to building and plumping the deep layers of the skin for exceptional results. Apple Stem Cell Extract protects the longevity of skin's own stem cells so your skin behaves like younger skin. Peptides stimulate matrix components to produce more collagen, and together with patented NeoGlucosamine reinforce collagen's surrounding support structure. The eye area appears more lifted, and crow's feet are smoothed from the inside out. NeoGlucosamine also inhibits a key enzyme in melanin formation, reducing the appearance of uneven pigmentation. Caffeine helps deflate puffiness under the eye, while hyaluronic acid acts as a natural moisture magnet. Vitamin E provides antioxidant benefits. The result is noticeably younger looking eyes. Ophthalmologist tested. Benefits of NeoStrata Skin Active Intensive Eye Therapy: Apple Stem Cell Extract preserves youthful look and vitality of skin Peptides stimulate matrix components to produce more collagen NeoGlucosamine reinforces collagen's surrounding support structure Caffeine reduces puffiness How to Use: Gently apply around the eye area until cream disappears. Use once daily for two weeks, then twice daily thereafter. Size: 15ml
You may also like
Discover more
We may earn a commission when you use our links to visit a store and make a purchase. We use cookies to enhance your experience with us. Read more. OK